Melissa Reimer-McAtee, Jose Serpa, Casey L McAtee, Emma Ortega, Anoma Somasunderam, Roberto Arduino, Rojelio Mejia, Netanya S Utay
{"title":"Impact of Intestinal Parasitic Infections on Gut Epithelial Barrier and Inflammation among Foreign-Born Persons Living with HIV.","authors":"Melissa Reimer-McAtee, Jose Serpa, Casey L McAtee, Emma Ortega, Anoma Somasunderam, Roberto Arduino, Rojelio Mejia, Netanya S Utay","doi":"10.4269/ajtmh.25-0068","DOIUrl":null,"url":null,"abstract":"<p><p>Increased enterocyte turnover, microbial translocation, and systemic inflammation have been demonstrated to serve as predictors of morbidity and mortality in people with HIV (PWH) receiving antiretroviral therapy. Both HIV and intestinal parasitic infections cause gut damage and increased microbial translocation. A prospective cohort study of foreign-born PWH with undetectable HIV RNA (<20 copies/mL) with and without intestinal parasitic coinfection was conducted. Biomarkers of enterocyte turnover (intestinal fatty acid binding protein [IFABP]), microbial translocation (soluble cluster of differentiation [CD]14), and systemic inflammation (soluble CD163) were measured. Stool parasite real-time quantitative polymerase chain reaction (qPCR) testing and Strongyloides stercoralis recombinant IgG ELISA (Strongy IgG) were used to diagnose parasitic infection. Of the 52 participants, 14 (27%) tested positive for infection with Strongyloides stercoralis by Strongy IgG, and five (11%) of the 45 participants who provided stool samples tested positive for a parasitic infection (not including Blastocystis) by stool qPCR. The median soluble CD (sCD)14 level in PWH with positive Strongy IgG results was significantly higher than in those with negative Strongy IgG results (1.69 µg/mL versus 1.48 µg/mL; P = 0.03). Soluble CD163 and IFABP levels did not differ significantly between groups. Participants with positive Strongy IgG results demonstrated an increase of 63.4 CD4+ T cells/µL (-161 to 195) after 316.2 (87 to 625) days after strongyloidiasis treatment (P = 0.035). Participants with both HIV and an intestinal parasite infection exhibited increased levels of sCD14, a marker of microbial translocation that has been shown to be an independent predictor of mortality in PWH, compared with those without parasitic infections. Interestingly, CD4+ T cells increased after strongyloidiasis treatment.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.25-0068","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Increased enterocyte turnover, microbial translocation, and systemic inflammation have been demonstrated to serve as predictors of morbidity and mortality in people with HIV (PWH) receiving antiretroviral therapy. Both HIV and intestinal parasitic infections cause gut damage and increased microbial translocation. A prospective cohort study of foreign-born PWH with undetectable HIV RNA (<20 copies/mL) with and without intestinal parasitic coinfection was conducted. Biomarkers of enterocyte turnover (intestinal fatty acid binding protein [IFABP]), microbial translocation (soluble cluster of differentiation [CD]14), and systemic inflammation (soluble CD163) were measured. Stool parasite real-time quantitative polymerase chain reaction (qPCR) testing and Strongyloides stercoralis recombinant IgG ELISA (Strongy IgG) were used to diagnose parasitic infection. Of the 52 participants, 14 (27%) tested positive for infection with Strongyloides stercoralis by Strongy IgG, and five (11%) of the 45 participants who provided stool samples tested positive for a parasitic infection (not including Blastocystis) by stool qPCR. The median soluble CD (sCD)14 level in PWH with positive Strongy IgG results was significantly higher than in those with negative Strongy IgG results (1.69 µg/mL versus 1.48 µg/mL; P = 0.03). Soluble CD163 and IFABP levels did not differ significantly between groups. Participants with positive Strongy IgG results demonstrated an increase of 63.4 CD4+ T cells/µL (-161 to 195) after 316.2 (87 to 625) days after strongyloidiasis treatment (P = 0.035). Participants with both HIV and an intestinal parasite infection exhibited increased levels of sCD14, a marker of microbial translocation that has been shown to be an independent predictor of mortality in PWH, compared with those without parasitic infections. Interestingly, CD4+ T cells increased after strongyloidiasis treatment.
期刊介绍:
The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine.
The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development.
The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal.
Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries